Boards Choose Continuity at the Top
Lumentum Sends Hurlston to Marvell’s Board
Lumentum Holdings (LITE) agreed to be acquired by Marvell in an all-stock transaction, and the leadership plan gives Lumentum one named seat at the buyer. Michael Hurlston is expected to join Marvell’s board after the deal closes, along with two other Lumentum-designated directors the filing did not name.
Hurlston, 59, has served as Lumentum’s chief executive since February 2025. He previously led Synaptics and Finisar, and he oversaw Finisar’s acquisition by II-VI. He also sits on Flex’s board, where Boardroom Alpha records a six-year tenure. Lumentum shareholders gave him 98% support at the November 2025 annual meeting.
Lumentum shares fell more than half from their October high by early November. The stock is still up about 42% a year over five years, a reminder that Marvell is buying after a huge run. The transaction is expected to close in the first half of 2028.
Our earlier coverage: Late-November meetings to watch, including Oracle, Estée Lauder and Lumentum (Nov. 2).
Marvell Keeps Murphy atop Combined Company
Marvell Technology (MRVL) agreed to a two-step merger that would make Lumentum a wholly owned subsidiary. Matt Murphy will remain chairman and chief executive of the combined company, which keeps the top office in Marvell’s hands.
Michael Hurlston, Lumentum’s chief executive, is expected to join Marvell’s board after closing. The filing names Hurlston but not the other two Lumentum directors expected to join him. Marvell has had eight directors exit in five years, so the incoming Lumentum seats will refresh a board that already has turnover.
Murphy keeps control of a stock that has gained about 53% in a year. The S&P gained about 9% over the same period. The merger is expected to close in the first half of 2028, subject to closing conditions.
Chord Sets Lou’s CEO Pay
Chord Energy (CHRD) put Michael Lou‘s CEO compensation in place after appointing him president and chief executive. Lou entered the role effective Oct. 19 and gets no extra pay for remaining a director.
Lou, 52, served as CFO and EVP at Oasis Petroleum and worked on the merger with Whiting Petroleum. He succeeds Daniel E. Brown, who had led Chord since April 2021. Boardroom Alpha records Lou with more than a dozen years as a public-company CFO across energy businesses.
Chord set Lou’s base salary at $950,000. His cash-incentive target is 125% of salary. The restricted-stock award covers 6,543 units. Chord’s stock has gained about 55% in a year, so Lou starts with room that many new energy chiefs do not get.
Also This Week
- Pfizer (PFE) appointed interim finance chief Cecile Guegan as permanent CFO on Nov. 1; her base salary is $1.3 million.
- Keysight Technologies (KEYS) named Jason Kary CFO effective Dec. 18, succeeding Neil Dougherty, who will provide transition services afterward.
- Sysco (SYY) confirmed interim finance chief Brandon Sewell as permanent CFO on Nov. 1; his base salary is $775,000.
- Toast (TOST) said Michael Senno will move from senior vice president of finance to CFO on Jan. 1.
- Erie Indemnity (ERIE) confirmed Timothy NeCastro‘s accelerated retirement for personal reasons and named Brian Bolash interim CEO on Nov. 3.
- Equity LifeStyle Properties (ELS) promoted COO Patrick Waite to CEO effective Jan. 1, with Marguerite Nader moving to executive vice chair.
- Genworth Financial (GNW) said CFO Jerome Upton will become CEO on Jan. 1, with Angela Simmons taking the finance seat.
- Indivior Pharmaceuticals (INDV) completed its merger with Supernus and installed Jack Khattar as CEO; Joseph Ciaffoni‘s separation is $1.7 million.
- Herbalife (HLF) appointed John DeSimone interim CEO and Scott Schaefer CFO on Nov. 1; the board is still searching.
- QuidelOrtho (QDEL) gave diagnostics heads Jonathan Siegrist and Bryan Hanson equity awards of $2 million each.
Executive Moves Filed This Week
CEO, CFO, COO, president and chair changes in SEC filings, Oct. 30 – Nov. 6, at U.S. companies over $500 million: 57 moves at 32 companies. Smaller companies, director and other officer moves are on the Boardroom Alpha platform.
| Company | Mkt cap | Who | Seat | In/Out | Effective | Filing |
|---|---|---|---|---|---|---|
| Pfizer(PFE) | $170.3B | Cecile Guegan | Interim CFO and Executive Vice President | In | Nov. 1, 2026 | 8-K |
| Marvell Technology(MRVL) | $117.1B | Michael Hurlston | CEO | In | Jun. 30, 2028 | 8-K |
| Lumentum(LITE) | $46.2B | Michael Hurlston | CEO | In | 8-K | |
| Keysight Technologies(KEYS) | $44.4B | Jason Kary | CFO | In | Dec. 18, 2026 | 8-K |
| Neil Dougherty | CFO | Out | Dec. 18, 2026 | 8-K | ||
| Sysco(SYY) | $37.0B | Brandon E. Sewell | CFO | In | Nov. 1, 2026 | 8-K |
| Toast(TOST) | $20.4B | Michael Senno | CFO | In | Jan. 1, 2027 | 8-K |
| Erie Indemnity(ERIE) | $13.2B | Timothy G. NeCastro | President and CEO | Out | Nov. 2, 2026 | 8-K |
| Brian W. Bolash | Interim President and CEO | In | Nov. 3, 2026 | 8-K | ||
| Equity Lifestyle Properties(ELS) | $12.3B | Marguerite Nader | CEO | Out | Jan. 1, 2027 | 8-K |
| Marguerite Nader | Executive Vice Chair of the Board | In | Jan. 1, 2027 | 8-K | ||
| Patrick Waite | President and CEO | In | Jan. 1, 2027 | 8-K | ||
| David Eldersveld | Expanded role adding COO | In | Jan. 1, 2027 | 8-K | ||
| Hinge Health(HNGE) | $9.4B | James Pursley | President | Out | Jan. 1, 2027 | 8-K |
| Daniel Perez | President | In | Jan. 1, 2027 | 8-K | ||
| Pool(POOL) | $7.7B | John E. Stokely | Interim Executive Chair | Out | Oct. 28, 2026 | 8-K |
| BGC(BGC) | $5.0B | Jean-Pierre Aubin | Vice Chairman | In | Dec. 31, 2026 | 8-K |
| Mercury Systems(MRCY) | $3.9B | William L. Ballhaus | Chairman of the Board | In | Oct. 28, 2026 | 8-K |
| Genworth Financial(GNW) | $3.4B | Thomas J. McInerney | President and CEO | Out | Dec. 31, 2026 | 8-K |
| Jerome T. Upton | CEO | In | Jan. 1, 2027 | 8-K | ||
| Angela R. Simmons | CFO | In | Jan. 1, 2027 | 8-K | ||
| Indivior Pharmaceuticals(INDV) | $3.3B | Joseph Ciaffoni | CEO | Out | Nov. 2, 2026 | 8-K |
| Ryan Preblick | CFO | Out | Nov. 2, 2026 | 8-K | ||
| Jack A. Khattar | CEO, Combined Company | In | Nov. 2, 2026 | 8-K | ||
| Timothy C. Dec | CFO, Combined Company | In | Nov. 2, 2026 | 8-K | ||
| Tony Kingsley | Chair of the Combined Company’s Board | In | Nov. 2, 2026 | 8-K | ||
| Recursion Pharmaceuticals(RXRX) | $2.2B | Fred Hassan | Chair of the Board and a Class II Director | In | Oct. 31, 2026 | 8-K |
| Harmony Biosciences(HRMY) | $1.9B | Jeffrey M. Dayno, M.D. | President and CEO | Out | Dec. 31, 2026 | 8-K |
| Peter Anastasiou | President and CEO | In | Jan. 1, 2027 | 8-K | ||
| Concentrix(CNXC) | $1.9B | Chinnu Susan Varghese | CFO | In | Dec. 1, 2026 | 8-K |
| Andre Valentine | CFO | Out | Dec. 1, 2026 | 8-K | ||
| Alamar Biosciences(ALMR) | $1.9B | Timothy “Tod” White | President | Out | Dec. 31, 2026 | 8-K |
| Gorman-Rupp(GRC) | $1.8B | David J. Daniels Jr. | Group President of the Gorman-Rupp Pumps | Out | Jan. 4, 2027 | 8-K |
| Frontier(ULCC) | $1.6B | Michael Delehant | COO | In | Nov. 30, 2026 | 8-K |
| Herbalife(HLF) | $1.6B | John DeSimone | Interim CEO | In | Nov. 1, 2026 | 8-K |
| Scott Schaefer | CFO | In | Nov. 1, 2026 | 8-K | ||
| Supernus Pharmaceuticals(SUPN) | $1.6B | Jack Khattar | CEO of the combined Supernus | In | Nov. 2, 2026 | 8-K |
| Tony Kingsley | Serving as Board Chair | In | Nov. 2, 2026 | 8-K | ||
| Upwork(UPWK) | $1.3B | Erica Gessert | CFO | Out | Jan. 1, 2027 | 8-K |
| Peter Sanborn | CFO | In | Jan. 1, 2027 | 8-K | ||
| Carter’s(CRI) | $1.2B | Richard F. Westenberger | But will continue serving as Carter’s CFO | In | 8-K | |
| Lindsay(LNN) | $1.1B | Michael Koch | CFO | In | Nov. 9, 2026 | 8-K |
| Brett Coburn | Interim Co-CFO | Out | Nov. 9, 2026 | 8-K | ||
| Alicia Pfeifer | Interim Co-CFO | Out | Nov. 9, 2026 | 8-K | ||
| Apogee Enterprises(APOG) | $959.5M | Donald A. Nolan | CEO | Out | Nov. 1, 2026 | 8-K |
| Fluence Energy(FLNC) | $940.5M | Julian Nebreda | President and CEO | Out | Oct. 30, 2026 | 8-K |
| Axel Meier | Interim President and CEO | In | Nov. 2, 2026 | 8-K | ||
| Ahmed Pasha | CFO | Out | Oct. 30, 2026 | 8-K | ||
| Ricardo Roizen | Interim CFO | In | Oct. 30, 2026 | 8-K | ||
| Mid Penn Bancorp(MPB) | $869.0M | Scott W. Micklewright | COO | In | Nov. 2, 2026 | 8-K |
| Heather Hall | President | In | Nov. 2, 2026 | 8-K | ||
| Syndax Pharmaceuticals(SNDX) | $843.6M | Keith A. Goldan | CFO | Out | Nov. 9, 2026 | 8-K |
| Aaron A. Ondrey | CFO | In | Nov. 9, 2026 | 8-K | ||
| Npk International(NPKI) | $723.4M | Gregg S. Piontek | CFO | Out | Aug. 31, 2027 | 8-K |
| Metallus(MTUS) | $650.2M | Kristopher Westbrooks | CEO | In | 8-K | |
| Mike Williams | CEO | Out | 8-K | |||
| Bank7(BSVN) | $556.7M | Anne Kain | President, Century Bank | In | Nov. 1, 2026 | 8-K |
CEO, CFO and Board Turnover Trends by Role and Sector
| Role | This Week | MTD | Last 12 Mo. | Prior 12 Mo. | YoY |
|---|---|---|---|---|---|
| CEO transitions | 10 | 10 | 513 | 524 | -2.1% |
| CFO transitions | 16 | 12 | 756 | 774 | -2.3% |
| Director adds | 54 | 46 | 2,812 | 2,908 | -3.3% |
| Director exits | 59 | 33 | 3,116 | 3,011 | +3.5% |
| Sector | # Co. | CEO · 30D | CEO · 1Y | CFO · 30D | CFO · 1Y |
|---|---|---|---|---|---|
| Consumer Defensive | 157 | 1.9% | 25.5% | 1.3% | 24.8% |
| Energy | 171 | 1.2% | 18.1% | 0.0% | 20.5% |
| Basic Materials | 145 | 1.4% | 17.2% | 0.7% | 22.1% |
| Consumer Cyclical | 366 | 1.6% | 15.8% | 2.2% | 23.0% |
| Communication Services | 140 | 0.7% | 15.0% | 2.9% | 23.6% |
| Industrials | 452 | 0.7% | 14.4% | 1.3% | 23.2% |
| Technology | 506 | 1.6% | 14.2% | 1.4% | 21.5% |
| Healthcare | 801 | 0.7% | 13.2% | 1.2% | 19.6% |
| Financial Services | 637 | 0.5% | 11.1% | 0.8% | 13.7% |
| Real Estate | 185 | 0.5% | 7.6% | 1.1% | 15.1% |
| Utilities | 77 | 1.3% | 5.2% | 2.6% | 22.1% |